Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort

Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort

<p>Abstract</p> <p>Background</p> <p>The risk of hepatotoxicity associated with different highly active antiretroviral therapy (HAART) regimens (containing multiple-protease inhibitors, single-protease inhibitors or non nucleoside reverse transcriptase inhibitors) in HI...

Full description

Bibliographic Details
Main Authors: Caputo Sergio Lo, Mazzotta Francesco, Sotgiu Giovanni, Minoli Lorenzo, Ladisa Nicoletta, Pastore Giuseppe, Bella Daniele, Quiros-Roldan Eugenia, Nelson Mark, Puoti Massimo, Casari Salvatore, Lapadula Giuseppe, Torti Carlo, Di Perri Giovanni, Filice Gaetano, Tinelli Carmine, Carosi Giampiero
Format: Article
Language:English
Published: BMC 2005-07-01
Series:BMC Infectious Diseases
Online Access:http://www.biomedcentral.com/1471-2334/5/58

Internet

http://www.biomedcentral.com/1471-2334/5/58

Similar Items